Tender Details
Ref No 24873418
Document

Tender Notice

Bidding

Not specified

Short Description

Development Of An Investment Project In The Technical Phase And Implementation Of Authors Supervision During The Performance Of The Facility Maintenance: Health Service In Upi Xхх-501.1547-Оод, Quarter 28 According To The Reg. Plan Of The Village Of Tsaratsvo, Municipality Maritsa, Pi With Identifier #78080.501.1547
Deadline *
Date 17 Mar 2026
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location Bulgaria
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

  • Ref No: 8259327
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Cre 2 5 Mg N1

  • Deadline: 10 May 2026
  • Ref No: 8260726
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Tab 10 Mg

  • Deadline: 10 May 2026
  • Ref No: 5310892
  • Location: Germany

Drug Contracts With An Option To Join

  • Deadline: 01 May 2026
  • Ref No: 5301821
  • Location: Bulgaria

Delivery Of Medicinal Products Which Are Included In Appendix 2 Of The Pds For The Needs Of Umbal Kanev Ad

  • Deadline: 27 May 2027
  • Ref No: 5396790
  • Location: Germany

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient L

  • Deadline: 27 Apr 2026

Concussion And Vestibular Physiotherapy Services

  • Deadline: 18 Mar 2026
  • Ref No: 4641976
  • Location: Germany

Medicines With The Active Ingredient Combination Oxycodone And Naloxone Atc N02Aa55

  • Deadline: 28 Feb 2026
  • Ref No: 4638957
  • Location: Germany

Medicines With The Active Ingredient Tacrolimus Atc L04Ad02

  • Deadline: 28 Feb 2026
  • Ref No: 5226107
  • Location: Germany

Medicines With The Active Ingredient Combination Vilanterol Umeclidinium Bromide And Fluticasone Furoate Atc R03Al08

  • Deadline: 31 Mar 2026
  • Ref No: 5976401
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf

  • Deadline: 10 May 2026
  • Ref No: 5965319
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine As An Otc Medi

  • Deadline: 10 May 2026
  • Ref No: 5968352
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine In The Dosage

  • Deadline: 10 May 2026
  • Ref No: 8271966
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ciprofloxacin Oht Atr

  • Deadline: 10 May 2026
  • Ref No: 8280171
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Prednisolone Atr

  • Deadline: 10 May 2026
WhatsApp Chat